Curevo logo

Curevo

curevovaccine.com

Curevo develops vaccines for varicella and herpes zoster, with a lead product candidate, amezosvatein, an adjuvanted subunit vaccine for the prevention of shingles in adults. The organization aims to improve patient experience and vaccination rates by offering a vaccine with non-inferior efficacy and improved reactogenicity compared to existing options.

Facts

HQ
Bothell, Washington, US
Sectors
Biotechnology Research
Founded
2017
Employees
30
Stage
Series B
Members see funding amounts.
.

Is this your organization? Claim it

Members see Curevo's funding rounds, amounts and investors.

Online